Importantly, blocking STAT signaling with the small-molecule inhibitor Ganetespib56 suppressed the nonautonomous growth-inducing effect of p53OE and IR on both breast and lung cancer cells (Fig. 4f, g, k, l, and supplementary Fig. 6). Here, SOAT1 is linked to lung carcinoma.